FDA Adverse Event Injury Summary report: N

ENDOMINA SYSTEM

MDR report key: 17340670 · Received July 18, 2023

Report

Report Number
3021721805-2023-07181
Event Type
Injury
Date Received
July 18, 2023
Date of Event
June 9, 2023
Report Date
July 18, 2023
Manufacturer
ENDO TOOLS THERAPEUTICS S.A
Product Code
OCW
UDI-DI
05425029282018
PMA / PMN Number
K211309
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
RISK MANAGER
Health Professional
N

Narratives

Description of Event or Problem · 0

DURING AN INTERVENTION USING THE ENDOMINA(R) SYSTEM ON (B)(6), 2023, AN ARTERIAL BLEEDING OCCURRED. INTRA-PROCEDURAL HEMOSTASIS WAS SUCCESSFULLY PERFORMED, AND THE PROCEDURE WAS APPROPRIATELY ABORTED. THE DEVICE WAS THROWN AWAY BY THE MEDICAL STAFF IN CHARGE OF THE PROCEDURE AND COULD NOT BE RETRIEVED. THE PATIENT WAS DISCHARGED THE NEXT DAY WITHOUT PROBLEM, AS INITIALLY PLANNED. THE VENDOR'S REPRESENTATIVE ONLY HAD CONFIRMATION OF THE PATIENT STATE OF HEALTH AND DAY OF DISCHARGE THROUGH A PHONE CALL TWO DAYS LATER. SINCE THE INCIDENT CONTACT WAS ESTABLISHED WITH THE SITE AND THE PHYSICIAN AT LEAST ONCE A WEEK. NO OTHER CONCERNS WERE RAISED. ON (B)(6), 2023, COMPANY RECEIVED A MEDWATCH FROM MAYO CLINIC REFERENCE (B)(4). CONTEXT: THE ENDOMINA CASE WAS THE FIRST ONE IN THIS HOSPITAL, THEREFORE, A PHYSICIAN EXPERT IN THE TECHNIQUE AND A VENDOR FIELD SPECIALIST CAME FOR PROCTORING. IT WAS IDENTIFIED THAT THE BLEEDING WAS RELATED TO THE USE OF THE DEVICES AND HAD BEEN CAUSED BY A USER ERROR. ROOT CAUSE ANALYSIS: THE DEVICE RESPONSIBLE FOR THE BLEEDING WAS THE ENDOMINA(R) PLATFORM/ AFTER UNBENDING THE ARM (BENDABLE COIL) OF THE PLATFORM, SOME TISSUE WAS CAUGHT INTO THE SYSTEM WITHOUT BEING DIRECTLY DETECTED. MOVEMENTS OF THE PLATFORM INDUCED BY USERS TO MOVE FORWARD WITH THE PROCEDURE TEARED THE GASTRIC WALL AND LED TO THE BLEEDING. THIS ROOT CAUSE ANALYSIS WAS DETERMINED BY THE VENDOR'S REPRESENTATIVE (FIELD CLINICAL SPECIALISTS) AND DISCUSSED WITH THE CLINICAL AFFAIRS DIRECTOR (LEAD FIELD CLINICAL SPECIALIST) WHO HAVE EXTENSIVE TECHNICAL KNOWLEDGE OF THE PRODUCTS. ALSO, THE TISSUE TEAR WAS CONFIRMED ORALLY BY THE PHYSICIAN PROCTORING THE ENDOSCOPIST. WORKING WITHOUT VISUAL CONTROL OR AGAINST RESISTANCE ARE DESCRIBED IN THE WARNINGS SECTION OF THE IFU. THE ROOT CAUSE ANALYSIS INVOLVING TAPES FOR THIS EVENT DOES NOT SEEM RELEVANT. IT COULD NOT EITHER HAVE BEEN A CONTRIBUTORY FACTOR. BY DESIGN, EVEN IF A MALFUNCTION OF THE SHEATH OCCURS THAT WOULD LET THE TIP OF THE NEEDLE PASS, IT COULD NOT LEAD TO SUCH A BLEEDING. INDEED, THE TIP OF THE NEEDLE OF TAPES ERROUNEOUSLY PASSING THROUGH THE COIL OF THE ENDOMINA(R) PLATFORM COULD ONLY LEAD TO SUPERFICIAL SCRATCHES. IN CONCLUSION, ENDO TOOLS THERAPEUTICS US CORP. CONFIRMS THE PRE-ROOT CAUSE ANALYSIS WRITTEN ON (B)(6), 2023 IN THE INTERNAL DOCUMENTATION. THE DEVICE CONTRIBUTORY OF THE INCIDENT IS THE ENDOMINA(R) PLATFORM. THE EVENT OCCURRED DUE TO UNBENDING WITHOUT VISUAL CONTROL AND MOVING THE DEVICE AGAINST RESISTANCE WHICH ARE CONTRAINDICATIONS OF THE IFU. FINALLY, THE PATIENT WAS SUPPOSED TO STAY OVERNIGHT, BY PLAN, BEFORE THE INCIDENT, AND THEREFORE NO PROLONGED HOSPITALIZATION WAS ACCOUNTED FOR.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
100856 ENDOMINA SYSTEM ENDOMINA PLATFORM PART OF ENDOMINA SYSTEM OCW ENDO TOOLS THERAPEUTICS S.A IA-EM8616610505-0 41398 05425029282018

Patients

Seq Age Sex Outcome Treatment
1 Female Hospitalization